A recent study of heart failure patients at UVA Health revealed that colchicine, a common gout medication, significantly improved survival rates.
Tag: heart and vascular
One of only 15 healthcare centers in the country with the expertise to treat FMD effectively, UVA Health Heart & Vascular is contributing to research efforts that could lead to new therapies for this complex and serious disease.
UVA Health is among the few high-volume cardiac care centers in the country with the requisite skills and dedicated expertise to tackle chronic total occlusion. Find out how we achieve high success rates and life-changing outcomes.
UVA presented live cases at the premier TVT Conference, including a new technique for patients who can’t be helped by standard treatment.
Researchers at UVA Health developed a new heart function measurement that could significantly reduce deaths and hospitalizations from systolic heart failure and pulmonary hypertension.
To more accurately identify risk factors for sudden cardiac death, UVA researchers are leading an international observational study evaluating data from an NIH-funded registry of hypertrophic cardiomyopathy patients.
Read about Wolf's efforts to apply the latest breakthroughs in genetics to the treatment of patients with heart disease.
UVA Heart and Vascular Center is now offering asymptomatic, at-risk patients easy access to comprehensive vascular screening.